On Wednesday (10th April): The Supreme Court of India expressed concern for public well-being, particularly regarding misleading advertisements and unregulated products. Justices emphasized that violations of the law, such as exploiting people’s trust with misleading claims, will not be tolerated. This relates to a recent contempt plea against Patanjali for marketing its product, Coronil, as a COVID-19 cure, violating drug advertising regulations.
